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Background: The amyloid cascade hypothesis characterizes the stereotyped progression of pathological changes 
in Alzheimer’s disease (AD) beginning with beta amyloid deposition, but does not address the reasons for amyloid 
deposition. Brain areas with relatively higher neuronal activity, metabolic demand, and production of reactive 
oxygen species in earlier life may have higher beta amyloid deposition in later life. The aim of this study was to 
investigate early life patterns of perfusion and late life patterns of amyloid deposition to determine the extent to 
which normative cerebral perfusion predisposes specific regions to future beta amyloid deposition. 
Materials and Methods: One hundred twenty-eight healthy, older human subjects (age: 56–87 years old; 44% 
women) underwent positron emission tomography (PET) imaging with [ 11 C]PiB for measures of amyloid burden. 
Cerebral perfusion maps derived from 47 healthy younger adults (age: 22–49; 47%) who had undergone single 
photon emission computed tomography (SPECT) imaging, were averaged to create a normative template, repre- 
sentative of young, healthy adults. Perfusion and amyloid measures were investigated in 31 cortical regions from 
the Hammers atlas. We examined the spatial relationship between normative perfusion patterns and amyloid 
pathophysiology. 
Results: The pattern of increasing perfusion (temporal lobe < parietal lobe < frontal lobe < insula/cingulate 
gyrus < occipital lobe; F(4,26) = 7.8, p = 0.0003) in young, healthy adults was not exactly identical to but 
approximated the pattern of increasing amyloid burden (temporal lobe < occipital lobe < frontal lobe < parietal 
lobe < insula/cingulate gyrus; F(4,26) = 5.0, p = 0.004) in older adults. However, investigating subregions within 
cortical lobes provided consistent agreement between ranked normative perfusion patterns and expected Thal 
staging of amyloid progression in AD (Spearman r = 0.39, p = 0.03). 
Conclusion: Our findings suggest that brain areas with normatively greater perfusion may be more susceptible 
to amyloid deposition in later life, possibly due to higher metabolic demand, and associated levels of oxidative 
stress and inflammation. 
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. Introduction 
The deposition of cerebral amyloid- 𝛽 throughout the cortical man-
le is a hallmark of Alzheimer’s disease (AD). Amyloid pathology is not
istributed uniformly [1] , and recent studies have turned to the exam-
nation of perfusion and metabolic patterns in the aging brain to help∗ Corresponding author at: Taub Institute for Research on Alzheimer’s Disease and
E-mail addresses: irenebmeier@gmail.com (I.B. Meier), amb2139@columbia.edu (
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666-2450/© 2020 Published by Elsevier B.V. This is an open access article under thxplain this regional variability [2 , 3] . The pattern of amyloid deposition
s associated with diminished regional cerebral blood flow (CBF) cross-
ectionally [4] . In animal models, mild chronic cerebral hypoperfusion
an create a metabolically deregulated microenvironment that triggers
ntry and accumulation of peripherally applied amyloid peptides [5] .
n the other hand, amyloid deposition in brain arteries may induce the Aging Brain, 630 West 168 th Street, PS 16, New York, NY 10032. 
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w  ypoperfusion via decreases in vasodilation [6] or impaired clearance of
athology [7] , and lead to subsequent neurological deficits [8] . Thus, it
s likely that there is a positive feedback loop in which vascular pertur-
ations potentiate amyloid pathology, which, in turn, decreases vascular
unction and affect metabolic processes. 
The association between amyloid and perfusion or metabolism can
e thought of as biphasic over the life course in which there is a pos-
tive association prior to downstream damage from amyloid accumu-
ation followed by a negative association after downstream damage
as occurred [9] . There is some evidence that amyloid deposition oc-
urs in areas of higher metabolism and activity [10] . Neuronal activ-
ty regulates amyloid precursor protein (APP) processing in the mam-
alian brain [11] , and brain regions in healthy adults with higher neu-
al activity are also the regions to accumulate amyloid in AD [9] . Sim-
larly, brain regions with higher metabolic demand may promote amy-
oid deposition via chronic oxidative stress and associated inflamma-
ory changes [12] . However, among symptomatic individuals, areas of
igh amyloid burden are associated with lower neuronal activity and
etabolism [9 , 13] . 
The extent to which regional blood perfusion patterns over long
eriods of time affect AD pathology deposition is less clear. In hu-
ans, long-term longitudinal studies (i.e., over decades) that exam-
ne patterns of cerebral perfusion and amyloid deposition are logisti-
ally difficult. To circumvent this issue, we examined the spatial dis-
ribution of fibrillar amyloid deposition in older adults as a function
f normative cerebral perfusion values derived from younger, healthy
dults. We tested whether increased amyloid is disproportionately
resent in areas that show normatively decreased or increased cerebral
erfusion. 
. Materials and methods 
.1. Participants 
One hundred twenty-eight older adults (mean age + SD = 69.7 + 6.2
ears, 44% women) [13] underwent detailed screening as well as neuro-
ogical and neuropsychological evaluation. While 24% of subjects were
lassified as amyloid positive, amyloid uptake was considered a contin-
ous variable due to its distribution of uptake values. Only individuals
ithout dementia and depression, defined by the Mini-Mental State Ex-
mination (scores > 27) for healthy controls, and according to standard
riteria for MCI [34] after a comprehensive clinical and neuropsycholog-
cal workup, and the Hamilton Depression Rating Scale [14] (17 item,
core < 12) were included. Exclusion criteria included neurologic, psy-
hiatric, or major medical illness, medication, or history of drug abuse
hat might affect cognition, as previously described [13] . Twenty-one
ercent of participants had mild cognitive impairment, and the remain-
ng were cognitively unimpaired. This research was approved the can-
onal ethics committee Zurich and informed consent was obtained from
ll participants. 
.2. PiB PET imaging 
Amyloid PET scans (intravenous administration of 350 MBq
 
11 C]PiB, GE Discovery PET/CT scanner) were performed in the Division
f Nuclear Medicine, Zurich University Hospital [15] . A maximum prob-
bility atlas was used to define regions of interest (ROIs) based on gray
nd white matter segmentation of each subject’s structural MRI scan.
ET images were co-registered with the subject’s T1-weighted MRI scan.
tandard uptake value ratios (SUVRs) were calculated with PET data 50–
0 min post-injection and a cerebellar reference region [13] . Subjects’
1-weighted MRI scans were spatially normalized to perform all further
nalyses in Montreal Neurological Institute (MNI) space [16] . Mean PiB
UVRs were calculated for 5 cortical lobes and 31 cortical subregions
efined by the Hammers Atlas [17] , averaging across hemispheres and
cross all subjects. 
f
.3. SPECT imaging and normative blood perfusion atlas 
Single photon emission computed tomography (SPECT; intravenous
dministration of 1000 MBq [ 99m Tc]ethylene cysteinate, Picker Prism
000 gamma camera) images from 47 young, healthy adults (mean
ge + SD = 34.3 + 7.6 yrs, 47% women; data from the Society of Nu-
lear Medicine Brain Imaging Council) were obtained for the creation
f a normative cerebral perfusion template [18] . Briefly, raw SPECT im-
ges were low-pass filtered (order = 4.0, cutoff= 0.26) and proportionally
caled to 0 to 1000 relative perfusion units. The normative perfusion
emplate was created by averaging each subject’s relative perfusion im-
ge in MNI space. Mean cerebral perfusion was calculated in the same
 cortical lobes and 31 cortical subregions of the Hammers atlas that
ere used to derive PiB SUVR values for direct comparison between
odalities and groups. 
.4. Statistical analyses 
Univariate analysis of variance (ANOVA) was used to determine
hether mean PiB SUVR differed across the 5 cortical lobes defined by
he Hammers atlas. We tested the omnibus effect and the mean differ-
nces across ROIs. Test statistics, degrees of freedom, and exact p-values
re shown for the omnibus effect, and 95% confidence intervals and
heir associated p-values are shown for pair-wise comparisons ( Table 1 ).
 Spearman correlation was used to test the association between ranked
ormative perfusion values and ranked mean PiB SUVR where each
ata point represents a cortical subregion. The Spearman correlation
ccounts for the non-independence of nearby subregions (e.g., within
he same lobe). 
. Theory 
Although it is unclear how blood perfusion patterns over time af-
ect AD and the underlying mechanisms that link cerebral perfusion to
myloid deposition are unknown, elevated synaptic activity increases
myloid levels in the interstitial fluid of the brain and increases vesicle
xocytosis, providing further evidence that metabolism may modulate
egion-specific amyloid deposition [19] . In transgenic AD mouse mod-
ls, endogenous neuronal activity regulates the regional concentration
f amyloid in the interstitial fluid, which drives local amyloid aggrega-
ion [19] . Compared with previous findings that focused on metabolism
30] , cerebral perfusion levels capture additional mechanical and phys-
cal factors such as blood pressure, vasodilation/constriction, blood vis-
osity and hemodynamics that could lead to regional vulnerability for
athology over long periods of time. 
There has been increasing attention placed on cerebrovascular con-
ributions to cognitive decline, especially given the high prevalence of
ementia due to multiple etiologies [20–22] . The association between
erebral perfusion and cognition has been investigated as a function
f amyloid burden in the Alzheimer’s Disease Neuroimaging Initiative
ADNI) study, where higher CBF in hippocampus, posterior cingulate,
nd precuneus was associated with poorer memory performance in amy-
oid positive individuals [23] . Studies also report a positive correlation
etween CBF and amyloid burden in the hippocampus, amygdala, and
audate, frontal, temporal, and insula of healthy individuals with high
evels of amyloid versus low amyloid burden, suggesting a compensatory
emodynamic mechanism aimed at maintaining stable blood perfusion
nd oxygen supply, and at protecting against pathology in early stages
f AD [24] . Furthermore, lower cerebral perfusion in symptomatic in-
ividuals compared to non-symptomatic individuals in the precuneus,
ntorhinal cortex, hippocampus, parietal cortex, and temporal cortex
as been reported [25 , 26] . Therefore, the association between higher
erebral perfusion and higher amyloid burden may be a transient event
hat surges before clinical disease onset and reverses as AD progresses,
hen downstream damage from amyloid may impair cerebrovascular
unction. 
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Table 1 
Posthoc pairwise comparisons of Normative Perfusion (above diagonal) and PiB SUVR (below diagonal) by Cortical Lobe. 
Table 2 
Rank Order of Normative Perfusion Values. 
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w  . Results 
Normative perfusion differed by cortical lobe (F(4,26) = 7.8,
 = 0.0003), and the general trend in normative perfusion was
s follows: temporal lobe < parietal lobe < frontal lobe < insula/cingulate
yrus < occipital lobe ( Fig. 1 ). Amyloid burden also differed by corti-
al lobe (F(4,26) = 5.0, p = 0.004), and the general trend was temporal
obe < occipital lobe < frontal lobe < parietal lobe < insula/cingulate gyrus
 Fig. 1 ). Post-hoc pairwise comparisons of normative perfusion and
ean PiB SUVR between cortical lobes are listed in Table 1 . Biomarker
alues of subregions are displayed as points within the boxplot for each
obe ( Fig. 1 ), each dot representing one subregion of the respective lobe.
Table 2 shows the ranked normative perfusion of subregions within
ortical lobes. Fig. 2 demonstrates the posterior to anterior gradient of
igh to low normative perfusion values. Taken together, Table 2 and
ig. 2 demonstrate that normative perfusion was not uniform within
ortical lobes. Areas with high amyloid burden and high normative per-
usion included posterior cingulate gyrus, insula, cuneus, lingual gyrus,
nd pre-subgenual anterior cingulate. Areas that had low amyloid bur- w  en and low normative perfusion values included parahippocampal and
mbient gyri, orbito-frontal cortex anterior orbital gyrus, orbito-frontal
ortex lateral orbital gyrus, anterior temporal lobe medial, and anterior
emporal lobe (inferior and lateral). Fig. 3 shows the positive Spearman
orrelation between ranked normative perfusion and ranked mean PiB
UVR for subregions ( r = 0.39, p = 0.03). 
. Discussion 
The observed distribution of amyloid in the older participants in-
luded in this study was similar to previously described patterns of
myloid PET [27–29] and amyloid pathology [1] . The pattern of in-
reasing normative perfusion in cortical lobes (temporal lobe < parietal
obe < frontal lobe < insula/cingulate gyrus < occipital lobe) was not en-
irely congruent with the pattern of increasing amyloid burden (tem-
oral lobe < occipital lobe < frontal lobe < parietal lobe < insula/cingulate
yrus) in older adults. The discrepancy between normative perfusion,
hich are heterogeneous across cortical lobes, and amyloid deposition,
hich are homogeneous across cortical lobes, suggest that increased
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Fig. 1. Boxplots of Normative Perfusion and Mean PiB 
SUVR by Cortical Lobe. 
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i  erebral perfusion may be one out of many factors that promote amyloid
eposition. 
The findings of a spatial relationship between perfusion patterns
n healthy, young adults and amyloid deposition in late life are con-
istent with the hypothesis that high metabolic demands throughout
ife promote AD pathology [30] . The distribution of aerobic glycolysis,
he metabolic pathway of converting glucose into pyruvate, in normal
oung adults is spatially and positively correlated with amyloid deposi-
ion in AD patients and healthy older adult controls with elevated amy-
oid [30] . As cerebral glucose metabolism and cerebral perfusion are
ightly linked, and to an extent, proxies of each other [31] , our findings
dd to a growing body of work that implicates increased metabolism in
arly life to the development of AD pathology in later life [9 , 30] . Glu-
ose and oxygen are necessary for neuronal function and are delivered to
eurons via astrocytes. Astrocytes also regulate vasodilation and hence,
ocal blood flow [32] , which could contribute to our observation. An
bservation in mice by Hawkes et al. (2013) suggests that the regional
ifferences in deposition of amyloid may be due to changing perivascu-
ar drainage of solutes and variations in vascular basement membrane
ith age, showing a thickening of capillary basement membrane in theerebral cortex, hippocampus, and the thalamus, but not in the stria-
um. It has also been proposed that amyloid-vulnerable brain regions are
haracterized by relatively low expression levels of gene sets involved
rotein synthesis and mitochondrial respiration [33] , adding further ev-
dence to the complexity of the pathophysiological mechanisms of AD
nd their impact on metabolism across the entire lifespan. 
The comparison of two independent samples rather than a within-
ubject design (i.e., comparing perfusion and amyloid levels within the
ame participants at the same point in time) enabled us to establish
ormative perfusion/metabolic patterns to determine whether pathol-
gy differs as a function of this inter-regional variability, and to in-
er whether perfusion patterns may precipitate amyloid pathology. Of
ourse, long-term longitudinal studies, in which cerebral perfusion is
easured at very young age and then participants are followed over
ecades, would be required to confirm our findings. For a longitudi-
al study, it would be necessary to measure cerebral perfusion in those
ho will eventually develop substantial amyloid pathology, prior to the
resence of amyloid pathology. 
While future studies will be necessary to determine the differential
mpact of factors and biomarkers associated with the aging brain, our
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Fig. 2. Mean normative blood perfusion and 
amyloid burden in all subregions of cortical 
lobes. 
Fig. 3. Spearman correlation between ranked SPECT and ranked PiB SUVR 
across subregions. Mean regional PiB SUVR value in each region of interest (ROI) 
of blood perfusion appreciated through SPECT. 
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tudy highlights the relevance of lifelong processes that may potentially
ifferentiate between healthy versus pathological aging. Limitations of
he study include the lack of access to data on APOE4 status of subjects,
he inclusion of differing amounts of white matter in Hammer atlas sub-
egions, and the different spatial resolution of PET and SPECT. Given
he available data, we were unable to restrict perfusion values to gray
atter. Therefore, the contribution of low perfusion in white matteray have contributed to the underestimaion of mean perfusion values
n regions defined by the Hammer atlas. The different amounts of white
atter in each Hammer atlas region may be have contributed to regional
ifferences (e.g., medial occipital lobe has little white matter and higher
erfusion compared to lateral occipital lobe). The partial volume effects
ntroduced by the inclusion of white matter and the different spatial res-
lution of the imaging modalities potentially introduced bias that was
ttenuated by spatially averaging across cortical lobes. Although we ob-
erved a spatial correlation between perfusion in the normative atlas and
myloid deposition in older participants, the effect sizes were modest.
hese findings are consistent with the hypothesis that the regionality
f amyloid pathology in older adults may be partially due to normative
erfusion patterns but highlight that there are likely many other con-
ributing factors. However, the novelty of this study lies in its design,
llowing the disassociation of regional early-life metabolic patterns from
ate-life pathology and hence raises the possibility that vascular factors
rior to amyloid deposition, such as increased cerebral blood perfusion,
ould promote AD pathogenesis. 
. Conclusions 
Our findings that there is a spatial overlap between early life perfu-
ion and late life amyloid burden suggest that the regional distribution of
myloid deposition may be a consequence of differential cerebral per-
usion patterns, such that areas with normatively greater perfusion in
arly life are potentially more susceptible to amyloid deposition in late
ife due to increased metabolic demand. 
I.B. Meier, P.J. Lao and A. Gietl et al. Cerebral Circulation - Cognition and Behavior 1 (2020) 100001 
D
A
 
D  
U  
o
 
e  
3  
d  
s  
o  
a
R
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
eclaration of Competing Interest 
Nothing to report. 
cknowledgements 
We thank all participants for their study participation. We thank
aniel Summermatter from Institute for Regenerative Medicine IREM,
niversity of Zurich, Switzerland, for help in setup and administration
f neuropsychological tests. 
This work was funded by Swiss National Foundation (Schweiz-
rischer Nationalfonds, SNF) grants 320030_125378/1 and
3CM30_124111 to CH, and P2EZP3_148738 to RSV; Synapsis Foun-
ation and Velux Foundation grants to IBM; and received institutional
upport from the Institute for Regenerative Medicine IREM, University
f Zürich and Institute for Biomedical Engineering University of Zürich
nd ETH Zürich, Switzerland. 
eferences 
[1] D.R. Thal , et al. , Phases of A beta-deposition in the human brain and its relevance
for the development of AD, Neurology 58 (12) (2002) 1791–1800 . 
[2] R.L. Buckner , et al. , Molecular, structural, and functional characterization of
Alzheimer’s disease: evidence for a relationship between default activity, amyloid,
and memory, J. Neurosci. 25 (34) (2005) 7709–7717 . 
[3] A.D. Cohen , et al. , Basal cerebral metabolism may modulate the cognitive effects of
Abeta in mild cognitive impairment: an example of brain reserve, J. Neurosci. 29
(47) (2009) 14770–14778 . 
[4] Z. Cselenyi , L. Farde , Quantification of blood flow-dependent component in esti-
mates of beta-amyloid load obtained using quasi-steady-state standardized uptake
value ratio, J. Cereb. Blood Flow Metab. 35 (9) (2015) 1485–1493 . 
[5] A. ElAli , et al. , Mild chronic cerebral hypoperfusion induces neurovascular dys-
function, triggering peripheral beta-amyloid brain entry and aggregation, Acta Neu-
ropathol. Commun. 1 (2013) 75 . 
[6] J.M. Price , et al. , Physiological levels of beta-amyloid induce cerebral vessel dys-
function and reduce endothelial nitric oxide production, Neurol. Res. 23 (5) (2001)
506–512 . 
[7] B.V. Zlokovic , The blood-brain barrier in health and chronic neurodegenerative dis-
orders, Neuron 57 (2) (2008) 178–201 . 
[8] F.L. Princz-Kranz , et al. , Vascular response to acetazolamide decreases as a function
of age in the arcA beta mouse model of cerebral amyloidosis, Neurobiol. Dis. 40 (1)
(2010) 284–292 . 
[9] W.J. Jagust , E.C. Mormino , Lifespan brain activity, beta-amyloid, and Alzheimer’s
disease, Trends Cognit. Sci. 15 (11) (2011) 520–526 . 
[10] R.L. Buckner , et al. , Cortical hubs revealed by intrinsic functional connectivity: map-
ping, assessment of stability, and relation to Alzheimer’s disease, J. Neurosci. 29 (6)
(2009) 1860–1873 . 
11] R.M. Nitsch , et al. , Release of amyloid beta-protein precursor derivatives by elec-
trical depolarization of rat hippocampal slices, Proc. Natl. Acad. Sci. USA 90 (11)
(1993) 5191–5193 . 
[12] M.F. Beal , Aging, energy, and oxidative stress in neurodegenerative diseases, Ann.
Neurol. 38 (3) (1995) 357–366 . [13] A.F. Gietl , et al. , Regional cerebral blood flow estimated by early PiB uptake is re-
duced in mild cognitive impairment and associated with age in an amyloid-depen-
dent manner, Neurobiol. Aging 36 (4) (2015) 1619–1628 . 
[14] M. Hamilton , A rating scale for depression, J. Neurol. Neurosurg. Psychiatry 23
(1960) 56–62 . 
[15] S.C. Steininger , et al. , Cortical amyloid beta in cognitively normal elderly adults is
associated with decreased network efficiency within the cerebro-cerebellar system,
Front. Aging Neurosci. 6 (2014) 52 . 
[16] A.C. Evans , et al. , Anatomical mapping of functional activation in stereotactic coor-
dinate space, Neuroimage 1 (1) (1992) 43–53 . 
[17] A. Hammers , et al. , Three-dimensional maximum probability atlas of the human
brain, with particular reference to the temporal lobe, Hum. Brain Mapp. 19 (4)
(2003) 224–247 . 
[18] C.M. Holland , et al. , Spatial distribution of white-matter hyperintensities in
Alzheimer disease, cerebral amyloid angiopathy, and healthy aging, Stroke 39 (4)
(2008) 1127–1133 . 
[19] A.W. Bero , et al. , Neuronal activity regulates the regional vulnerability to amyloid–
beta deposition, Nat. Neurosci. 14 (6) (2011) 750–756 . 
[20] A.M. Brickman , Contemplating Alzheimer’s disease and the contribution of white
matter hyperintensities, Curr. Neurol. Neurosci. Rep. 13 (12) (2013) 415 . 
[21] A. Kapasi , C. DeCarli , J.A. Schneider , Impact of multiple pathologies on the threshold
for clinically overt dementia, Acta Neuropathol. 134 (2) (2017) 171–186 . 
[22] B. Yew , D.A. Nation , I. Alzheimer’s , Disease Neuroimaging, Cerebrovascular resis-
tance: effects on cognitive decline, cortical atrophy, and progression to dementia,
Brain 140 (7) (2017) 1987–2001 . 
[23] K.J. Bangen , et al. , Cerebral blood flow and amyloid-beta interact to affect memory
performance in cognitively normal older adults, Front. Aging Neurosci. 9 (2017)
181 . 
[24] A. Fazlollahi , et al. , Increased cerebral blood flow with increased amyloid burden in
the preclinical phase of alzheimer’s disease, J. Magn. Reson. Imaging (2019) . 
[25] F.C. Maier , et al. , Longitudinal PET-MRI reveals beta-amyloid deposition and rCBF
dynamics and connects vascular amyloidosis to quantitative loss of perfusion, Nat.
Med. 20 (12) (2014) 1485–1492 . 
[26] N. Mattsson , et al. , Association of brain amyloid-beta with cerebral perfusion and
structure in Alzheimer’s disease and mild cognitive impairment, Brain 137 (Pt 5)
(2014) 1550–1561 . 
[27] C.R. Jack Jr. , et al. , Tracking pathophysiological processes in Alzheimer’s disease: an
updated hypothetical model of dynamic biomarkers, Lancet Neurol. 12 (2) (2013)
207–216 . 
[28] J. Sepulcre , et al. , In vivo tau, amyloid, and gray matter profiles in the aging brain,
J. Neurosci. 36 (28) (2016) 7364–7374 . 
[29] D.R. Thal , J. Attems , M. Ewers , Spreading of amyloid, tau, and microvascular pathol-
ogy in Alzheimer’s disease: findings from neuropathological and neuroimaging stud-
ies, J Alzheimers Dis 42 (Suppl 4) (2014) S421–S429 . 
[30] A.G. Vlassenko , et al. , Spatial correlation between brain aerobic glycolysis and
amyloid-beta (Abeta ) deposition, Proc. Natl. Acad. Sci. USA 107 (41) (2010)
17763–17767 . 
[31] O.B. Paulson , et al. , Cerebral blood flow response to functional activation, J. Cereb.
Blood Flow Metab. 30 (1) (2010) 2–14 . 
[32] L. Welberg , Brain metabolism: astrocytes bridge the gap, Nat. Rev. Neurosci. 10 (2)
(2009) 86-86 . 
[33] M.J. Grothe , et al. , Molecular properties underlying regional vulnerability to
Alzheimer’s disease pathology, Brain 141 (9) (2018) 2755–2771 . 
[34] B. Winblad , K. Palmer , M. Kivipelto , et al. , Mild cognitive impairment–beyond con-
troversies, towards a consensus: report of the International Working Group on Mild
Cognitive Impairment., J. Intern. Med. (2004) . 
